Nanobiotix (NBTX) Stock Chart & Stock Price History $19.68 -0.21 (-1.03%) As of 03:03 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Nanobiotix Stock Price Performance The Nanobiotix (NBTX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 295.67%, with a year-to-date return of 585.19%. In the past month, the stock has increased 127.47%, reflecting recent market activity. As of the latest close, Nanobiotix traded at $19.88 with a market cap of $953.05 million and volume of 202,726 shares. Receive NBTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nanobiotix and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+21.09%1 Month Performance+127.47%3 Month Performance+292.51%Year-To-Date Performance+585.19%1 Year Performance+295.67% NBTX Stock Chart for Friday, October, 3, 2025 NBTX Chart by TradingView Nanobiotix Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/02/2025$18.74$19.88+6.08%$21.12$19.59202,726 shs$953.05 million10/01/2025$18.89$18.74-0.79%$19.72$18.00160,402 shs$898.45 million09/30/2025$18.02$18.89+4.83%$21.00$18.88272,600 shs$905.59 million09/29/2025$16.24$18.02+10.96%$18.49$15.85167,265 shs$863.88 million09/26/2025$14.75$16.24+10.10%$16.49$15.4443,217 shs$778.55 million09/25/2025$16.44$14.75-10.28%$15.38$14.4661,037 shs$707.16 million09/24/2025$14.45$16.44+13.77%$16.98$14.30130,086 shs$788.13 million09/23/2025$12.86$14.45+12.36%$15.07$13.3047,501 shs$692.73 million09/22/2025$11.57$12.86+11.15%$13.43$12.63100,565 shs$616.55 million09/19/2025$12.31$11.57-6.01%$12.30$10.5868,520 shs$554.70 million Get the Latest News and Ratings for NBTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Nanobiotix and its competitors with MarketBeat's FREE daily newsletter. 09/18/2025$10.61$12.31+16.08%$13.20$11.62343,217 shs$590.14 million09/17/2025$9.74$10.61+8.88%$10.96$10.07346,108 shs$508.40 million09/16/2025$9.32$9.74+4.51%$10.22$9.7216,841 shs$466.97 million09/15/2025$9.70$9.32-3.92%$9.83$9.325,122 shs$446.80 million09/12/2025$9.89$9.70-1.87%$10.46$9.705,500 shs$465.02 million09/11/2025$9.56$9.89+3.37%$10.19$9.878,369 shs$473.89 million09/10/2025$9.30$9.56+2.83%$10.00$9.1012,610 shs$458.48 million09/09/2025$8.71$9.30+6.77%$9.54$8.9011,604 shs$445.84 million09/08/2025$8.55$8.71+1.93%$8.91$8.4112,285 shs$417.56 million09/05/2025$8.52$8.55+0.29%$8.70$8.282,490 shs$409.65 million09/04/2025$8.65$8.52-1.45%$8.59$8.037,577 shs$408.47 million09/03/2025$8.46$8.65+2.25%$9.14$8.483,673 shs$414.44 million09/02/2025$8.94$8.46-5.43%$8.67$8.258,929 shs$405.33 million Related Companies Travere Therapeutics Stock Chart 89BIO Stock Chart Agios Pharmaceuticals Stock Chart Mesoblast Stock Chart Recursion Pharmaceuticals Stock Chart Disc Medicine Stock Chart Ocular Therapeutix Stock Chart ANI Pharmaceuticals Stock Chart Arcutis Biotherapeutics Stock Chart Adaptive Biotechnologies Stock Chart Receive NBTX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Nanobiotix and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NBTX) was last updated on 10/3/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredU.S. Government Sparking Crypto RallyU.S. Puts GDP on the Blockchain Could this spark the next crypto supercycle? Discover the altcoins poised t...Crypto 101 Media | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTilson: “I’m watching HOOD”A strange chasm is coming to Wall Street... It's already creating millionaires and billionaires at the fast...Stansberry Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredChina’s message to TrumpPorter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredIs Nvidia about to Trigger Another 150X Opportunity?Nvidia gave investors a chance to make more than 150 times their money with its AI chips, known as graphics pr...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nanobiotix S.A. Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Nanobiotix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NBTX Stock Alerts